SCHEMBL5779655

SCHEMBL5779655

COc1cc([N+](=O)[O-])ccc1OCCN1CCC(OC(N)=O)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRA1A P35348 2/20 0.49
▸ ADRA1B P35368 2/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ ALDH1A1 P00352 5/20 0.46
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ DRD3 P35462 2/20 0.44
▸ DRD2 P14416 1/20 0.44
▸ HTR1A P08908 2/20 0.43
▸ HTR7 P34969 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3863019 0.89 ALDH1A1 (0.49) ADRA1AADRA1BSMN1; SMN2NPC1CYP1A2
SCHEMBL3860586 0.87 ADRA1A (0.49) ADRA1AADRA1BSMN1; SMN2NPC1CYP1A2
SCHEMBL5783873 0.84 ADRA1A (0.53) ADRA1AADRA1BSMN1; SMN2ALDH1A1KMT2A
SCHEMBL3863267 0.84 KDM4E (0.53) ADRA1AADRA1BSMN1; SMN2NPC1CYP1A2
SCHEMBL4024622 0.82 HTR2C (0.54) CYP1A2CYP2D6CYP2C9CYP2C19HTR2B
SCHEMBL264564 0.81 LTA4H (0.57) SMN1; SMN2NPC1CYP1A2CYP3A4CYP2D6
SCHEMBL5381777 0.81 LTA4H (0.54) SMN1; SMN2NPC1CYP1A2CYP3A4CYP2D6
SCHEMBL5257435 0.81 MCHR1 (0.50) ADRA1AADRA1BSMN1; SMN2NPC1CYP1A2
SCHEMBL5257155 0.81 MCHR1 (0.50) ADRA1AADRA1BSMN1; SMN2NPC1CYP1A2
SCHEMBL6313154 0.81 ALDH1A1 (0.59) SMN1; SMN2NPC1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1708698-A1 3-(4-PIPERIDINE-1YLMETHYL-PHENYL)-PROPION ACID-PHENYLAMIDE-DERIVATIVES AND RELATED COMPOUNDS USED IN THE FORM OF MCH ANTAGONISTS (MELANINE CONCENTRATING HORMONE) FOR TREATING EATING DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-10-11 — — EP disclosed
WO-2005063239-A9 3-(4-PIPERIDINE-1YLMETHYL-PHENYL)-PROPION ACID-PHENYLAMIDE-DERIVATIVES AND RELATED COMPOUNDS USED IN THE FORM OF MCH ANTAGONISTS (MELANINE CONCENTRATING HORMONE) FOR TREATING EATING DISORDERS BOEHRINGER INGELHEIM INT (DE) 2006-03-09 — — WO disclosed
WO-2005063239-A1 3-(4-PIPERIDINE-1YLMETHYL-PHENYL)-PROPION ACID-PHENYLAMIDE-DERIVATIVES AND RELATED COMPOUNDS USED IN THE FORM OF MCH ANTAGONISTS (MELANINE CONCENTRATING HORMONE) FOR TREATING EATING DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-07-14 — — WO disclosed
Send feedback